www.bewet.fora.pl
Wszystko o zwierzętach.
FAQ
Szukaj
Użytkownicy
Grupy
Galerie
Rejestracja
Profil
Zaloguj się, by sprawdzić wiadomości
Zaloguj
Forum www.bewet.fora.pl Strona Główna
->
Zwierzaki w potrzebie
Napisz odpowiedź
Użytkownik
Temat
Treść wiadomości
Emotikony
Więcej Ikon
Kolor:
Domyślny
Ciemnoczerwony
Czerwony
Pomarańćzowy
Brązowy
Żółty
Zielony
Oliwkowy
Błękitny
Niebieski
Ciemnoniebieski
Purpurowy
Fioletowy
Biały
Czarny
Rozmiar:
Minimalny
Mały
Normalny
Duży
Ogromny
Zamknij Tagi
Opcje
HTML:
NIE
BBCode
:
TAK
Uśmieszki:
TAK
Wyłącz BBCode w tym poście
Wyłącz Uśmieszki w tym poście
Kod potwierdzający: *
Wszystkie czasy w strefie EET (Europa)
Skocz do:
Wybierz forum
Sklep
----------------
Informacje i opinie.
Promocje.
Konkursy.
Pomoc dla zwierząt
----------------
Zwierzaki w potrzebie
Bewet pomaga
Żywienie,higiena,zdrowie.
----------------
Żywienie, higiena, zdrowie.
Artykuły dla zwierząt.
----------------
Artykuły dla zwierząt.
Nasi ulubieńcy.
----------------
Nasi ulubieńcy.
Przegląd tematu
Autor
Wiadomość
maurs3u8ktan
Wysłany: Śro 6:45, 25 Maj 2011
Temat postu: Ed Hardy Caps1Eqlb, Bmy Buys Zgen And Zran Buys Tu
Labs, Inc. (Pink:EQLB) announced a 300% increase in revenues for the first quarter 2010 compared to the fourth quarter 2009 in one of its key sales regions. The sales region encompasses Las Vegas and the surrounding area and the numbers were derived predominantly from EQ's sales in 43 convenience store locations. This record breaking quarter also followed a strong Q4 2009. EQLB continues to see positive trends in all of its key markets.
The building of the EQ brand was a key initiative for the company in 2010. As a result of the market's acceptance of EQ as a powerful and healthy energy drink, EQ's "Smart Energy Drink" has performed well in major retailers in additional key markets including New York, California and Florida.
EQLB offers EQ Smart Energy Drink, an effervescent tablet that provides instant energy to any beverage. Consisting of a blend of essential vitamins, Gingko Biloba, and less caffeine than a cup of coffee, EQ keeps you going any time - day or night.
EQLB's EQ contains 80mg of caffeine, comparable to many other energy-based products currently on the market. EQ is a stimulant which wards off drowsiness and restores alertness and improves breathing.
It's the Labor Day weekend that seems to be the most anticipated weekend for the people of America. Labor Day in 2010 is on Monday, the 6th of September.
On this weekend people simply want to move for those places where different celebration process use to occur.
Las Vegas is expecting over 2 million visitors for the 2010 Holiday, so expect an energized weekend packed with visitors.
EQLB has launched a nationwide promotion at the Las Vegas Boulevard location of Walgreens on Labor Day weekend.
The promotion, which began on Labor Day weekend, and will allow one lucky purchaser of EQLB's EQ Smart Energy Drink to receive a free personal poker seminar from poker celebrity Vanessa Rousso. Ms. Rousso has an international reputation as one of the best poker players in the world.
Another lucky winner will receive a personal thrill ride from champion Baja racer
Ed Hardy Caps
, T.J. Flores, later this year. T.J. and the LVDC Race Team, based out of Las Vegas, NV, are the 2008 Over all Off-road Champs and the winner of the 2008 and 2009 Mint 400. EQLB intends to add at least one additional celebrity to the promotion on Labor Day weekend.
Bristol-Myers Squibb Company (NYSE:BMY) and ZymoGenetics, Inc. (NASDAQ:ZGEN) announced that the companies have signed a definitive agreement providing for the acquisition of ZGEN by BMY, for $9.75 per share in cash. The transaction, with an aggregate purchase price of approximately $885 million, or approximately $735 million net of cash acquired, has been unanimously approved by the boards of directors of both companies.
The board of directors of ZGEN intends to recommend that ZGENs shareholders tender their shares in the tender offer. In addition, shareholders holding approximately 37% of the outstanding shares of ZGENs common stock have entered into agreements with BMY to support the transaction and to tender their shares in the offer.
Bristol-Myers Squibb gains the following as a result of the acquisition:
Full ownership of pegylated-interferon lambda, a novel interferon in Phase IIb development for the treatment of Hepatitis C infection, which, if approved, could be an important contributor to Bristol-Myers Squibbs future growth. The companies have collaborated on the development of pegylated-interferon lambda since January 2009. Four-week and 12-week results from a Phase IIa study will be presented at the American Association for the Study of Liver Diseases meeting later this year.
RECOTHROM, a recombinant thrombin approved by the U.S. Food and Drug Administration for use as a topical hemostat to control non-arterial bleeding during surgical procedures.
IL-21 protein, a cytokine currently being tested in an open-label, Phase II clinica
fora.pl
- załóż własne forum dyskusyjne za darmo
Powered by
phpBB
© 2001, 2005 phpBB Group
Regulamin